Join our Community

Support ToI and remove all ads

Learn more

English
Français
עברית

Get The Daily Edition
Account
Sign In
- Sign in
- Join our Community

Open Search form

Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate Israel
The Blogs
Podcasts
Community(members only)

Newsletters
Partners

Input search

English
Français
עברית

Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate Israel
The Blogs
Podcasts
Community(members only)
Video
Newsletters
Partners
Community
- Join our community
- Sign in
- About The Times of Israel
- Advertise on The Times of Israel
- Contact us
- Download our App
  - For IOS users
  - For Android users
- Get the Daily Edition
- Follow us
- © 2026 The Times of Israel , All Rights Reserved
  
  Terms and conditions Privacy policy Your Privacy Rights

Input search

Tech Israel

Daily Updates from Silicon Wadi for Sunday, December 27, 2020

Facebook
Twitter

View previous edition

View next edition

Limaca Medical says it has developed a medical device to perform endoscopic ultrasound-guided biopsies that promise 'ten times' greater procedural efficiency (Courtesy)

Drilling tissue for biopsies, startup eyes better tumor samples

By Shoshanna Solomon

Israel’s Limaca Medical says it has developed a medical device to perform endoscopic ultrasound-guided biopsies with ‘ten times’ greater procedural efficiency

Outbrain suggests interesting and relevant content to users, and powers many publishing sites including that of CNN, Fox News and Slate (Shoshanna Solomon/TimesofIsrael)

Content discovery firm Outbrain reportedly seeks IPO at $2 billion valuation

By Shoshanna Solomon

Decision to hold share sale on Wall Street comes as merger with competitor Taboola fails, TheMarker says

People wearing face masks shop at the Mahane Yehuda Market in Jerusalem on December 25, 2020. (Yonatan Sindel/Flash90)

Israel starts 3rd lockdown Sunday, as it ramps up vaccine distribution

6,000 cops being deployed to enforce closure, with focus on dispersing gatherings and New Year’s Eve parties, and cracking down on quarantine violations

Doses of the Pfizer-Biontech COVID-19 coronavirus vaccine at a vaccination center in Magdeburg, eastern Germany, on December 27, 2020. (Ronny Hartmann / POOL / AFP)

Inside StoryPatient flow at emergency sites planned using Lego figures

How BioNTech-Pfizer won the great global coronavirus vaccine race

By Hui Min NEO, Yannick Pasquet, Michelle Fitzpatrick and Yann Schreiber

As the German biotechnology firm worked on a shot to defeat virus, other companies around the country already began organizing the infrastructure needed to deliver it to billions

Undated file photo shows a volunteer receiving the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (John Cairns/University of Oxford via AP, File)

AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19

By AFP

Following criticism over initial trial, pharma giant’s CEO believes general efficacy will be equal to Pfizer-BioNTech, Moderna; says data will be published ‘at some point’

The 2020 Genesis Prize is awarded at the President's Residence in Jerusalem, December 24, 2020 (Mark Neyman/GPO)

Genesis Prize gives award to 10 Israeli firms helping combat COVID-19

By Shoshanna Solomon

Natan Sharansky, recipient of the $1 million prize in 2019, funded competition of tech companies with ‘most promising’ innovations to fight the pandemic

Not just cheerleaders: Journalists’ role in covering UAE-Israel normalization

Media on both sides can work together, telling the story warts and all to ensure leaders take public feedback on their actions into account

View Edition by Date

November	December 2020					January
Mo	Tu	We	Th	Fr	Sa	Su
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

The Times of Israel

TECH ISRAEL

FREE, DAILY TO YOUR INBOX

The email is either missing or invalid.

By signing up, you agree to our terms You hereby accept The Times of Israel Terms of Use and Privacy Policy, and you agree to receive the latest news & offers from The Times of Israel and its partners or ad sponsors.

Advertisement

Advertisement

Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate Israel
The Blogs
podcasts
video

terms and conditions
privacy policy
Your Privacy Rights
about us
advertise with us
Jobs at The Times of Israel
contact us

Community

Join our community
Sign in

Get the Daily Edition

Enter your email address

Follow us on Facebook Follow us on Instagram Follow us on Whatsapp Follow us on X Follow us on Youtube Follow us on Telegram Follow us on Threads Follow us on Bluesky

© 2026 The Times of Israel, all rights reserved

Concept, design & development by

Developed by

Powered by

Never miss breaking news on Israel

Get notifications to stay updated

You're subscribed

Register for free
and continue reading

Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.

Email address

Please use the following structure: example@domain.com

Or Continue with

By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.

Send me The Times of Israel Daily Edition

Register to continue

Email address

Or Continue with

Log in to continue

Email address

Something went wrong.
Please try again in a few minutes..

Sign in or Register

Email address * Password *

Incorrect password. Please try again or choose an option below.

I forgot my password / Send me a sign in link

Or Continue with

check your email

Check your email

We sent an email to you at .

It has a link that will sign you in.

Click the link in that email to complete your registration.